Clairo

Principal Statistical Programmer

India

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Digital Health, Clinical Research, Data ScienceIndustries

Requirements

Candidates must possess a Ph.D. with over 5 years of relevant industry experience, an M.S. with over 7 years, or a B.S. with over 10 years of experience in clinical trials, preferably within a CRO or pharmaceutical research organization. A strong proficiency in SAS programming, including the creation, testing, and maintenance of CDISC-compliant datasets (SDTM, ADaM), experience with electronic submission packages and regulatory interactions (e.g., FDA), and familiarity with clinical protocols and Statistical Analysis Plans are essential. Experience with TFL generation is a plus. A solid understanding of the pharmaceutical drug development process, proficiency in Windows and Microsoft Office products, demonstrated leadership experience and/or training, excellent verbal and written communication skills, and strong organizational and analytical abilities are also required. The ability to work both independently and in a team setting, with flexibility to adapt to changing priorities, is necessary.

Responsibilities

The Principal Statistical Programmer will lead and coordinate all statistical programming activities for cardiac safety trials, developing, testing, and maintaining SAS code to generate CDISC-compliant datasets (SDTM, ADaM). Responsibilities include producing and maintaining submission-ready datasets and electronic submission packages in accordance with FDA guidelines, creating and implementing data standards and macros, and researching new programming techniques. The role involves generating and interpreting compliance checks on CDISC-formatted datasets and supporting statistical analyses and regulatory requirements through client-facing discussions. Additionally, the Principal Statistical Programmer will manage direct reports, conduct onboarding and training, mentor junior staff, and lead team strategy meetings. They will also identify and implement process improvements, develop and maintain SOPs, SWIs, templates, and playbooks, and drive initiatives for future analyses, data quality, and standardization. Collaboration with cross-functional teams, management of client commitments, maintenance of deliverable statuses, and provision of consultation during sponsor and regulatory teleconferences are also key duties.

Skills

SAS
CDISC
SDTM
ADaM
define.xml
reviewer's guide
FDA guidelines
data standards
macros
statistical programming
data processing
data analysis
compliance checks
regulatory requirements
SOPs
SWIs
templates
playbooks

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI